D
Denali Therapeutics Inc. DNLI
$15.15 $0.261.75%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- -100.00%
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- -100.00%
Cost of Revenue -13.76% 9.47% -5.43% -16.92% 25.61%
Gross Profit 13.76% -11.04% -105.15% -14.24% -41.40%
SG&A Expenses 21.36% -1.48% -3.55% -7.02% 5.33%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -7.56% 7.06% -5.70% -15.20% 21.49%
Operating Income 7.56% -8.25% -168.39% -9.47% -33.35%
Income Before Tax 3.98% -7.89% -154.00% 7.27% -21.04%
Income Tax Expenses 126.67% -- -- -- 600.00%
Earnings from Continuing Operations 3.95% -7.89% -154.00% 7.27% -21.07%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 3.95% -7.89% -154.00% 7.27% -21.07%
EBIT 7.56% -8.25% -168.39% -9.47% -33.35%
EBITDA 6.31% -8.37% -166.36% -17.44% -36.58%
EPS Basic 21.93% 12.36% -143.83% 15.26% -16.37%
Normalized Basic EPS 29.63% 12.35% -143.84% 1.45% -31.86%
EPS Diluted 21.93% 12.36% -145.38% 15.26% -16.37%
Normalized Diluted EPS 29.63% 12.35% -145.08% 1.45% -31.86%
Average Basic Shares Outstanding 23.03% 23.11% 23.19% 9.43% 4.04%
Average Diluted Shares Outstanding 23.03% 23.11% 19.80% 9.43% 4.04%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings